GO:1903352 L-ornithine transmembrane transport: Amino Acid Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903352 describes the directed movement of L-ornithine across a membrane, a biological process essential for nitrogen disposal, polyamine biosynthesis, and arginine metabolism.
• L-ornithine transport is mediated by membrane proteins including cationic amino acid transporters and periplasmic binding-protein-dependent systems, as demonstrated for related basic amino acids.
• In prokaryotes and eukaryotes, L-ornithine uptake is coupled to polyamine transport and acid resistance mechanisms, linking transport to stress survival.
• Dysregulated L-ornithine transport contributes to cancer cell growth, where L-arginine and L-ornithine availability supports proliferation.
• Experimental models for studying L-ornithine transport include brush border membrane vesicles, transporter-overexpressing cell lines, and bacterial transport mutants.
• CRISPR-based knockout, knock-in, and overexpression models enable causal interrogation of candidate L-ornithine transporters in human cells and model organisms.
Description
L-ornithine transmembrane transport (GO:1903352) is the directed movement of the amino acid L-ornithine across a biological membrane. This process is fundamental to nitrogen metabolism, because L-ornithine serves as a central intermediate in the urea cycle and as a precursor for polyamines, which are required for cell growth and proliferation. In both prokaryotes and eukaryotes, the uptake and efflux of L-ornithine are mediated by dedicated membrane transport systems that maintain intracellular amino acid homeostasis. The importance of L-ornithine transport extends to human physiology and disease. In cancer cells, the transport of cationic amino acids such as L-arginine and L-ornithine is stimulated by growth factors and supports rapid proliferation. In bacteria, L-ornithine transport is linked to acid resistance and polyamine metabolism, contributing to survival in hostile environments. The study of L-ornithine transmembrane transport therefore bridges basic membrane biology, metabolic regulation, and translational research. Researchers investigating this process rely on a combination of biochemical transport assays, genetic models, and structural approaches to define the molecular players and their regulation.
L-ornithine transmembrane transport At A Glance
| GO ID | GO:1903352 |
|---|---|
| GO term | L-ornithine transmembrane transport |
| Ontology | biological_process |
| Synonym | None |
| Definition | The directed movement of L-ornithine across a membrane. |
| Major function | Maintains intracellular L-ornithine pools for polyamine synthesis, urea cycle, and nitrogen metabolism. |
| Related processes | Polyamine transport, acid resistance, cationic amino acid transport. |
| Cellular location | Plasma membrane, inner membrane, and organellar membranes. |
| Representative transporters | CAT1 (SLC7A1), periplasmic binding-protein-dependent systems (e.g., ArtPIQMJ). |
What Is GO:1903352?
According to the Gene Ontology, GO:1903352 (L-ornithine transmembrane transport) is defined as the directed movement of L-ornithine across a membrane. This biological process encompasses the translocation of the amino acid L-ornithine from one side of a lipid bilayer to the other, typically mediated by integral membrane transport proteins. The term does not specify the mechanism (e.g., facilitated diffusion, secondary active transport, or primary active transport) or the direction (influx or efflux), but it requires that the movement be directed and specific for the L-isomer of ornithine. The process is distinct from the transport of other amino acids such as L-arginine or L-lysine, although some transporters may exhibit overlapping substrate specificity.
Why Is L-ornithine transmembrane transport Important in Cell Biology?
L-ornithine transmembrane transport is critical because L-ornithine is a hub metabolite at the intersection of nitrogen disposal, polyamine biosynthesis, and cell growth regulation. In eukaryotes, the transport of L-ornithine across the plasma membrane and mitochondrial membranes determines substrate availability for the urea cycle and for ornithine decarboxylase, the rate-limiting enzyme in polyamine synthesis. In prokaryotes, L-ornithine transport systems contribute to acid resistance and polyamine homeostasis, which are important for survival in the host environment. Moreover, the transport of cationic amino acids including L-ornithine is upregulated in cancer cells in response to growth factors, supporting the metabolic demands of proliferation. Understanding the molecular mechanisms of L-ornithine transport is therefore relevant to cancer biology, infectious disease, and metabolic disorders.
• Provides L-ornithine for the urea cycle, enabling efficient nitrogen disposal in ureotelic organisms.
• Supplies the precursor for polyamine biosynthesis, which is essential for cell proliferation and differentiation.
• Contributes to acid resistance in bacteria by supporting arginine-ornithine antiport and polyamine production.
• Is upregulated in cancer cells to meet the increased demand for cationic amino acids during rapid growth.
• Plays a role in viral receptor engagement, as CAT1 (a cationic amino acid transporter) also serves as a receptor for certain viruses.
• Represents a potential therapeutic target for diseases characterized by dysregulated polyamine metabolism.
• Can be studied using membrane vesicle systems that allow precise kinetic characterization of transport.
• Involves periplasmic binding-protein-dependent systems in bacteria, which are models for understanding substrate specificity.
• Is linked to probiotic functions in swine-derived Lactobacillus salivarius, where amino acid transport contributes to host-microbe interactions.
• Offers opportunities for CRISPR-based functional genomics to identify and validate novel transporters.
What Happens During L-ornithine transmembrane transport?
Substrate Recognition and Binding
In simple terms: The transporter first recognizes and grabs L-ornithine on one side of the membrane.
The initial step in L-ornithine transmembrane transport is the specific recognition of the substrate by a membrane-embedded transport protein. In cationic amino acid transporters such as CAT1, the substrate binding site accommodates the positively charged side chain of L-ornithine through electrostatic interactions with conserved acidic residues. In bacterial periplasmic binding-protein-dependent systems, a soluble periplasmic binding protein first captures L-ornithine with high affinity and delivers it to the membrane-spanning transport complex. This substrate recognition step ensures selectivity against other amino acids, although some transporters exhibit broad specificity for cationic amino acids.
Conformational Change and Translocation
In simple terms: The transporter changes shape to move L-ornithine across the membrane.
Upon substrate binding, the transporter undergoes a series of conformational changes that translocate L-ornithine across the lipid bilayer. For secondary active transporters, this process is coupled to the movement of ions (e.g., Na+ or H+) down their electrochemical gradient. Structural studies of CAT1 have revealed that the transporter alternates between outward-facing and inward-facing states, allowing the substrate to be released on the opposite side of the membrane. In periplasmic binding-protein-dependent systems, ATP hydrolysis drives the transport cycle, inducing conformational changes in the transmembrane domains.
Energy Coupling and Driving Forces
In simple terms: The transport is powered by energy sources such as ion gradients or ATP.
L-ornithine transport can be energized by different mechanisms depending on the system. In many eukaryotic cells, cationic amino acid transport is facilitated by the membrane potential and the concentration gradient of the substrate itself. In bacteria, acid resistance antiporters couple L-ornithine transport to proton gradients, exchanging L-arginine for L-ornithine to maintain cytoplasmic pH. Periplasmic binding-protein-dependent systems utilize ATP-binding cassette (ABC) transporters, where ATP hydrolysis provides the energy for substrate translocation. These diverse energy-coupling mechanisms reflect the adaptation of L-ornithine transport to different physiological contexts.
Release and Intracellular Utilization
In simple terms: Once inside, L-ornithine is released and used by the cell.
After translocation, L-ornithine is released into the cytoplasm or organelle lumen, where it enters metabolic pathways. In eukaryotes, L-ornithine is a substrate for ornithine decarboxylase in polyamine synthesis and for carbamoyl phosphate synthetase in the urea cycle. In bacteria, intracellular L-ornithine can be decarboxylated to putrescine, which contributes to acid resistance and polyamine pools. The release step is often coupled to the reverse conformational change of the transporter, resetting it for another cycle.
Regulation of Transport Activity
In simple terms: The cell controls how much L-ornithine is transported based on its needs.
L-ornithine transport activity is regulated at multiple levels. In mammalian cells, growth factors stimulate the transport of cationic amino acids including L-ornithine, supporting proliferation. The expression of transporter genes can be induced by substrate availability or stress conditions. In bacteria, acid resistance antiporters are activated by low pH, ensuring L-ornithine transport is prioritized under acidic stress. Post-translational modifications and protein-protein interactions may also modulate transporter activity, although specific mechanisms for L-ornithine transporters require further study.
Key Genes Involved in GO:1903352 L-ornithine transmembrane transport
The following genes and proteins have been experimentally implicated in L-ornithine transmembrane transport or in the transport of closely related cationic amino acids, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC7A1 (CAT1) | Cationic amino acid transporter; mediates transport of L-ornithine, L-arginine, and L-lysine | Structural studies reveal substrate binding and viral receptor engagement |
| artP | Periplasmic binding protein for L-arginine/L-ornithine in E. coli | Component of the ArtPIQMJ transport system; model for substrate specificity |
| artI | Membrane-spanning component of the ArtPIQMJ transport system | Essential for L-arginine/L-ornithine uptake in bacteria |
| artQ | Membrane-spanning component of the ArtPIQMJ transport system | Forms the translocation channel with ArtI |
| artM | ATP-binding cassette component of the ArtPIQMJ system | Provides energy for transport via ATP hydrolysis |
| artJ | Periplasmic binding protein of the ArtPIQMJ system | Binds L-arginine/L-ornithine with high affinity |
| adiA | Arginine decarboxylase; converts L-arginine to agmatine, linked to acid resistance | Indirectly affects L-ornithine pools and transport |
| speF | Ornithine decarboxylase; converts L-ornithine to putrescine | Links L-ornithine transport to polyamine synthesis |
| potE | Putrescine-ornithine antiporter | Exchanges putrescine for L-ornithine, contributing to acid resistance |
| SLC7A2 (CAT2) | Cationic amino acid transporter; transports L-ornithine and L-arginine | Potential redundancy with CAT1 in L-ornithine uptake |
| SLC3A2 (4F2hc) | Heavy chain of heteromeric amino acid transporters | Associates with light chains to form functional transporters |
| ODC1 | Ornithine decarboxylase; consumes L-ornithine for polyamine synthesis | Downstream metabolic fate of transported L-ornithine |
| OTC | Ornithine transcarbamylase; uses L-ornithine in the urea cycle | Mitochondrial utilization of L-ornithine |
| ARG1 | Arginase; produces L-ornithine from L-arginine | Intracellular source of L-ornithine for transport |
| Ligilactobacillus salivarius transport genes | Amino acid transport systems in probiotic bacteria | Probiotic functions linked to amino acid metabolism |
| SLC7A11 | Cystine/glutamate antiporter; not a primary L-ornithine transporter | Related to amino acid transport studies |
| SLC25A15 | Mitochondrial ornithine transporter | Transports L-ornithine across the inner mitochondrial membrane |
| SLC25A2 | Mitochondrial ornithine transporter | Facilitates L-ornithine transport for urea cycle |
How Is L-ornithine transmembrane transport Regulated?
L-ornithine transmembrane transport is regulated by substrate availability, hormonal signals, and stress conditions. In mammalian cells, growth factors such as epidermal growth factor stimulate the transport of cationic amino acids including L-ornithine, supporting cell proliferation. The expression of cationic amino acid transporters can be induced by amino acid deprivation or inflammatory signals, although specific transcriptional regulators for L-ornithine transporters are not fully defined. In bacteria, acid resistance antiporters are activated by low pH, and the expression of genes encoding L-ornithine transport systems is controlled by stress-responsive transcription factors. Additionally, the intracellular concentration of L-ornithine itself can feedback on transport activity, but the molecular details of this regulation remain to be elucidated.
L-ornithine transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC7A1 (CAT1) | Cancer proliferation; viral entry receptor | Knockout in cancer cell lines; viral infection assays |
| SLC25A15 | Hyperammonemia; urea cycle disorders | Knockout mouse models; mitochondrial transport assays |
| artPIQMJ | Bacterial acid resistance; pathogenesis | Bacterial knockout mutants; pH stress assays |
| ODC1 | Polyamine metabolism; cancer | Overexpression and knockout in mammalian cells |
| speF/potE | Bacterial acid resistance; polyamine homeostasis | Bacterial mutants; transport assays |
Cancer Metabolism and Proliferation
L-ornithine transmembrane transport supports the metabolic reprogramming of cancer cells by supplying L-ornithine for polyamine biosynthesis and arginine metabolism. In a human colon cancer cell line, growth factor stimulation increased L-arginine transport, which is closely related to L-ornithine transport. Elevated polyamine levels are a hallmark of many cancers, and the transport of L-ornithine is a potential target for therapeutic intervention. Targeting L-ornithine transporters could disrupt polyamine homeostasis and inhibit tumor growth, although specific inhibitors are not yet clinically available.
Infectious Disease and Bacterial Pathogenesis
In bacteria, L-ornithine transport systems contribute to acid resistance, which is essential for survival in the acidic environment of the stomach and phagolysosomes. The arginine-ornithine antiporter and related systems help maintain cytoplasmic pH and polyamine pools. Periplasmic binding-protein-dependent transport systems for L-arginine and L-ornithine are important for bacterial growth and virulence. Inhibiting these transport systems could reduce bacterial fitness and represent a novel antibacterial strategy.
Metabolic Disorders and Urea Cycle Defects
L-ornithine transport across the mitochondrial membrane is required for the urea cycle. Defects in mitochondrial ornithine transporters can lead to hyperammonemia and related metabolic disorders. Although direct mutations in L-ornithine transporters have not been extensively characterized in human disease, impaired transport could contribute to urea cycle dysfunction. Studying L-ornithine transport in model systems may reveal new therapeutic targets for hyperammonemia.
Viral Entry and Receptor Function
The cationic amino acid transporter CAT1 (SLC7A1) serves as a receptor for certain viruses, in addition to its role in L-ornithine transport. Structural insights into CAT1 have revealed how viral receptor engagement occurs, linking L-ornithine transport to viral pathogenesis. This dual function highlights the importance of understanding the molecular details of L-ornithine transport for antiviral drug development.
From L-ornithine transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC7A1 mediate L-ornithine transport in human cells? | SLC7A1 knockout and overexpression in HEK293 or HeLa cells |
| What is the role of mitochondrial ornithine transporters in urea cycle? | SLC25A15 knockout hepatocytes or mouse models |
| How do bacteria regulate L-ornithine transport under acid stress? | E. coli artPIQMJ deletion mutants; pH-controlled growth |
| Can L-ornithine transport be targeted in cancer? | Cancer cell lines with inducible knockdown of cationic amino acid transporters |
| What is the structural basis of L-ornithine recognition? | Point mutations in transporter binding site; cryo-EM or X-ray crystallography |
| Does probiotic L. salivarius transport L-ornithine? | L. salivarius knockout mutants; metabolite profiling |
How to Study the L-ornithine transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled transport assay | Uptake of L-ornithine over time | Kinetic characterization in membrane vesicles |
| CRISPR knockout | Loss-of-function effects on transport | Validation of candidate transporters |
| Cryo-EM/X-ray crystallography | Three-dimensional structure of transporters | Substrate binding and conformational changes |
| Metabolomics | Intracellular levels of L-ornithine and related metabolites | Pathway flux and polyamine synthesis |
| RNA-seq | Expression of transporter genes | Regulation under stress or growth conditions |
| Proteomics | Protein abundance of transporters | Validation of expression changes |
| Site-directed mutagenesis | Functional impact of specific residues | Identification of binding site residues |
| Bacterial growth assays | Fitness under acid stress | Role of transport in acid resistance |
Transport Assays with Membrane Vesicles
Brush border membrane vesicles and bacterial inner membrane vesicles are classical systems for measuring L-ornithine transport kinetics. These assays use radiolabeled L-ornithine to quantify uptake over time and determine kinetic parameters such as Km and Vmax. Vesicle systems allow precise control of ionic gradients and membrane potential, enabling dissection of driving forces. They are particularly useful for studying transporters that are difficult to express in heterologous systems.
Genetic Knockout and Knockdown Models
CRISPR-Cas9 knockout and RNA interference knockdown are powerful approaches to test the requirement of specific genes for L-ornithine transport. For example, knocking out SLC7A1 in human cells can reveal its contribution to L-ornithine uptake. Bacterial deletion mutants of artPIQMJ have been used to demonstrate the role of this system in L-arginine and L-ornithine transport. These models can be combined with metabolic labeling to trace L-ornithine flux.
Structural Biology and Molecular Dynamics
Structural studies using cryo-electron microscopy or X-ray crystallography provide atomic-level insights into L-ornithine recognition and translocation. The structure of CAT1 has revealed the substrate binding pocket and the conformational changes required for transport. Molecular dynamics simulations can complement these structures to visualize the transport cycle and identify key residues. Such approaches are essential for rational design of transporter inhibitors.
Metabolomics and Flux Analysis
Metabolomic profiling and stable isotope tracing can quantify L-ornithine and its downstream metabolites (e.g., polyamines, citrulline) in cells and tissues. These methods have been applied to study probiotic functions of L. salivarius, revealing changes in amino acid metabolism. Flux analysis using 15N-labeled L-ornithine can measure transport rates and metabolic fate in living cells. Combining metabolomics with genetic perturbations provides a systems-level view of L-ornithine transport.
How CRISPR Can Be Used to Study GO:1903352 L-ornithine transmembrane transport
Knockout
CRISPR-Cas9 knockout of candidate L-ornithine transporter genes (e.g., SLC7A1, SLC25A15, artP) enables loss-of-function studies to determine their contribution to L-ornithine transport. Knockout cell lines can be subjected to radiolabeled transport assays to measure residual uptake, revealing redundancy or essentiality. In bacteria, CRISPR-based knockout of artPIQMJ genes can be used to study acid resistance and polyamine metabolism.
Point Mutation
Point mutations introduced by CRISPR base editing or homology-directed repair can dissect the substrate binding site of L-ornithine transporters. For example, mutating conserved residues in CAT1 can reveal their role in substrate recognition and viral receptor function. Such models are valuable for understanding structure-function relationships and for validating drug binding sites.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous transporter loci allows real-time visualization and quantification of transporter expression and localization. Tagged knock-in models of SLC7A1 or SLC25A15 can be used for imaging and proteomic studies. Knock-in of disease-associated mutations can model transport defects in human cells.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of L-ornithine transporters can increase transport capacity and study downstream metabolic effects. Overexpression of CAT1 in cancer cells can enhance L-ornithine uptake and support proliferation. Such models are useful for testing whether increased transport is sufficient to drive polyamine synthesis and cell growth.
How EDITGENE Supports L-ornithine transmembrane transport Research
Researchers studying L-ornithine transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in substrate uptake, metabolic flux, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of transporters and associated pathways.
Contact EDITGENE today to design your custom CRISPR model for L-ornithine transmembrane transport research.
Frequently Asked Questions About L-ornithine transmembrane transport
What is L-ornithine transmembrane transport?
L-ornithine transmembrane transport (GO:1903352) is the directed movement of the amino acid L-ornithine across a biological membrane, mediated by specific transport proteins.
What genes are involved in L-ornithine transmembrane transport?
Key genes include SLC7A1 (CAT1), SLC25A15, and bacterial artPIQMJ genes, which encode transporters or binding proteins for L-ornithine and related cationic amino acids.
Why is L-ornithine transport important for cancer?
L-ornithine transport supplies the precursor for polyamine synthesis, which supports rapid cancer cell proliferation; growth factors stimulate cationic amino acid transport in cancer cells.
How is L-ornithine transported across bacterial membranes?
Bacteria use periplasmic binding-protein-dependent systems such as ArtPIQMJ and antiporters like PotE to transport L-ornithine, often coupled to acid resistance.
What diseases are linked to L-ornithine transport defects?
Defects in mitochondrial L-ornithine transport can contribute to urea cycle disorders and hyperammonemia; dysregulated transport is also linked to cancer and bacterial pathogenesis.
What methods are used to study L-ornithine transport?
Common methods include radiolabeled transport assays in membrane vesicles, CRISPR knockout models, structural biology, and metabolomics.
Can CRISPR be used to study L-ornithine transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of L-ornithine transporters in human cells and bacteria.
What is the role of CAT1 in L-ornithine transport?
CAT1 (SLC7A1) is a cationic amino acid transporter that mediates L-ornithine uptake and also serves as a viral receptor.
How is L-ornithine transport regulated?
It is regulated by growth factors, substrate availability, and stress conditions such as low pH in bacteria.
What are the research tools for L-ornithine transport?
Tools include knockout cell lines, tagged knock-in models, overexpression systems, and CRISPR library screens, available from EDITGENE.
Conclusion
L-ornithine transmembrane transport (GO:1903352) is a fundamental biological process that connects amino acid metabolism, polyamine biosynthesis, and cellular stress responses. Its dysregulation is implicated in cancer, metabolic disorders, and bacterial pathogenesis, making it a compelling target for basic and translational research. Advances in structural biology and CRISPR-based functional genomics are rapidly expanding our understanding of the transporters and regulatory mechanisms involved. Continued investigation of L-ornithine transport will likely reveal new therapeutic opportunities and deepen our knowledge of membrane transport biology.
References
- 1. Biber J et al.. 1983. Transport of L-cystine by rat renal brush border membrane vesicles.. Pflugers Arch 396(4):335-41 PMID: 6844138
- 2. Igarashi K et al.. 1999. Polyamine transport in bacteria and yeast.. Biochem J 344 Pt 3(Pt 3):633-42 PMID: 10585849
- 3. Xia L et al.. 2025. Structural insights into cationic amino acid transport and viral receptor engagement by CAT1.. Nat Commun 17(1):1108 PMID: 41408058
- 4. Yang J et al.. 2023. Genomic and metabonomic methods reveal the probiotic functions of swine-derived Ligilactobacillus salivarius.. BMC Microbiol 23(1):242 PMID: 37648978
- 5. Cendan JC et al.. 1995. Characterization and growth factor stimulation of L-arginine transport in a human colon cancer cell line.. Ann Surg Oncol 2(3):257-65 PMID: 7641023
- 6. Igarashi K et al.. 2010. Characteristics of cellular polyamine transport in prokaryotes and eukaryotes.. Plant Physiol Biochem 48(7):506-12 PMID: 20159658
- 7. Krammer EM et al.. 2019. Function and Regulation of Acid Resistance Antiporters.. J Membr Biol 252(4-5):465-481 PMID: 31240358
- 8. Wissenbach U et al.. 1995. A third periplasmic transport system for L-arginine in Escherichia coli: molecular characterization of the artPIQMJ genes, arginine binding and transport.. Mol Microbiol 17(4):675-86 PMID: 8801422
